Last reviewed · How we verify
NCT03995693
Fuel Selection During Eccentric Cycling With Glucose Ingestion
NA trial testing Solution ingestion in Exercise in 75 participants. Completed in 1 December 2021.
1 December 2021
Quick facts
| Lead sponsor | Université de Montréal |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 75 |
| Start date | 1 August 2019 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Solution ingestion
- Constant load arm cranking
- Expired gas sampling
- Indirect respiratory calorimetry
- Blood sampling — full drug profile →
- Measure of maximal voluntary contraction force production
- Measure of muscle electrical activity (EMG)
- Measure of central and cutaneous temperatures
- Measure of perceived exertion, pain perception and affective response
- Measure of sweat and urine production
Conditions studied
- Exercise — all drugs for Exercise →
- Damage Muscle — all drugs for Damage Muscle →
- Nutrition — all drugs for Nutrition →
Sponsor
Université de Montréal — full company profile →
Who can join
Adults 18 to 45, male only, with Exercise or Damage Muscle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study compares fuel selection during eccentric and concentric cycling, with (placebo) or without glucose ingestion during exercise. After a 2-week familiarization and habituation with the ergometers, subjects will complete four experimental conditions in a randomized order: concentric with placebo, eccentric with placebo, concentric with glucose, eccentric with glucose.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03995693
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Solution ingestion
Trials testing the same drug.
- NCT04084808 — Maple Products and Cognitive Performance During High Intensity Intermittent Exercise (HIIE) · NA · completed
- NCT02880124 — Maple Products and Exercise Performance · NA · completed
Other recruiting trials for Exercise
Currently open trials in the same condition.
- NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
- NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
- NCT07498530 — Virtual Assistant for Exercise Adherence in Older ADULTS · NA · recruiting
- NCT07426172 — Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism. · NA · recruiting
- NCT07276477 — Inspiratory Muscle Training After Stroke · NA · recruiting
Other Université de Montréal trials
Trials by the same sponsor.
- NCT07389837 — Maple Syrup Carbohydrate Dose-Response on 20-km Cycling Time-Trial Performance · NA · not yet recruiting
- NCT07259382 — Neuro-Inflammation in Extremity Trauma: Risk Verification in Elbow Trauma: The NERVE Study · not yet recruiting
- NCT07194629 — Pilot and Feasibility Study of Impact of SDF 38% Application on Oral Health of Elderly With Autonomy Loss · Phase 4 · not yet recruiting
- NCT06527274 — Effect of Defocus in Soft Contact Lenses on Internal Retinal Vascularization · NA · active not recruiting
- NCT06634264 — Comparison of Two Reeducation Methods in Children With Persistent Sleep Apnea, a Randomized Controlled Trial · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03995693 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Université de Montréal
- Last refreshed: 17 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03995693.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing